This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
MediciNova (focused primarily on developing compounds for urological and gynecological conditions) has netted $113.4mm (Y11.9bn) with its initial public offering of 31.6mm shares (including the overallotment) priced at $3.88 each. The company, which exceeded its hopes of bringing in $100mm, sold shares to Japanese and other ex-US investors and is now listed on the Hercules Market of the Osaka Securities Exchange
Drug Discovery Tools
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?